Position in IMUX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,036,921
+$288,047 QoQ
Shares Held
67,464
-0.0% QoQ
Ownership
0.494%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#23
of 55 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMUX Over Time
Shares Held
Position Value (USD)
Derivatives in IMUX
reported options exposure · as of Mar 31, 2025CallValue
$693,022
CallShares
63,580
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. IMUX ranks #68 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
328,635 | $43,793,900 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,059,730 | $41,287,080 | |
| 3 | ALMS |
Alumis Inc.
|
870,548 | $24,497,220 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
72,842 | $24,386,773 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
388,682 | $22,594,084 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
478,500 | $17,804,985 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
504,559 | $15,555,553 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
2,148,359 | $14,866,644 |
All Filings in IMUX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,036,921 | 67,464 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $748,874 | 674,662 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $360,269 | 674,662 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $806,297 | 914,170 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $638,090 | 914,170 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $996,445 | 914,170 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $693,022 | 635,800 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $635,800 | 635,800 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $1,614,170 | 1,614,170 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $814,268 | 493,496 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $547,780 | 493,496 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,128,338 | 1,612,378 | Shares | Sole | 2024-05-17 | |
| 2023-12-31 | $675,000 | 450,000 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $661,500 | 450,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,631,500 | 650,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $968,500 | 650,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $910,000 | 650,000 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $213,405 | 61,500 | Put | Sole | 2022-08-12 | |
| 2022-06-30 | $213,405 | 61,500 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $694,950 | 61,500 | Put | Sole | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||